13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001172661-26-001093
Total Value
$308.4M
Positions
29
Other Managers
2
Confidential Omitted
No
Holdings (29)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 374,000 | $28.2M | 9.15% |
| 2 | AMYLYX PHARMACEUTICALS INC | AMLX | 1,750,000 | $21.1M | 6.85% |
| 3 | ZURA BIO LTD | ZURA | 3,815,930 | $20.0M | 6.48% |
| 4 | DISC MEDICINE INC | IRON | 250,000 | $19.9M | 6.44% |
| 5 | RAPT THERAPEUTICS INC | 75382E208 | 581,187 | $19.7M | 6.38% |
| 6 | IMMUNOVANT INC | IMVT | 750,000 | $19.1M | 6.18% |
| 7 | SOLENO THERAPEUTICS INC | SLNO | 400,000 | $18.5M | 6.00% |
| 8 | VOR BIOPHARMA INC | VOR | 1,370,107 | $17.9M | 5.81% |
| 9 | DIANTHUS THERAPEUTICS INC | DNTH | 350,000 | $14.4M | 4.68% |
| 10 | JADE BIOSCIENCES INC | JBIO | 806,273 | $12.4M | 4.03% |
| 11 | KALVISTA PHARMACEUTICALS INC | KALV | 685,632 | $11.1M | 3.59% |
| 12 | CONTINEUM THERAPEUTICS INC | CTNM | 800,000 | $9.1M | 2.96% |
| 13 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 1,200,000 | $9.1M | 2.94% |
| 14 | FULCRUM THERAPEUTICS INC | FULC | 800,000 | $9.0M | 2.93% |
| 15 | NEKTAR THERAPEUTICS | NKTR | 210,732 | $8.9M | 2.89% |
| 16 | UPSTREAM BIO INC | UPB | 300,000 | $8.1M | 2.64% |
| 17 | NEUROGENE INC | NGNE | 350,000 | $7.2M | 2.34% |
| 18 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 300,000 | $6.9M | 2.24% |
| 19 | CONTEXT THERAPEUTICS INC | CNTX | 4,683,711 | $6.9M | 2.23% |
| 20 | CULLINAN THERAPEUTICS INC | CGEM | 634,032 | $6.6M | 2.13% |
| 21 | EVOMMUNE INC | EVMN | 325,000 | $5.6M | 1.80% |
| 22 | ORUKA THERAPEUTICS INC | ORKA | 183,330 | $5.6M | 1.80% |
| 23 | SILENCE THERAPEUTICS PLC | SLNCF | 808,032 | $4.9M | 1.59% |
| 24 | UNICYCIVE THERAPEUTICS INC | UNCY | 796,558 | $4.6M | 1.49% |
| 25 | CLIMB BIO INC | CLYM | 979,534 | $3.9M | 1.27% |
| 26 | SANA BIOTECHNOLOGY INC | SANA | 700,000 | $2.8M | 0.92% |
| 27 | PHARVARIS N V | PHVS | 82,800 | $2.3M | 0.75% |
| 28 | AVALO THERAPEUTICS INC | AVTX | 124,666 | $2.3M | 0.73% |
| 29 | REZOLUTE INC | RZLT | 951,809 | $2.2M | 0.73% |